Ipratropium bromide and Pemetrexed disodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ipratropium bromide (ipratropium bromide) and Pemetrexed disodium (pemetrexed disodium). Common drug interactions include neck pain among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Ipratropium bromide and Pemetrexed disodium. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

What is Pemetrexed disodium?

Pemetrexed disodium has active ingredients of pemetrexed disodium. eHealthMe is studying from 4,270 Pemetrexed disodium users. Check the latest studies of Pemetrexed disodium.



On Jul, 18, 2026

15 people who take Ipratropium bromide and Pemetrexed disodium together, and have interactions are studied.

Ipratropium bromide and Pemetrexed disodium drug interactions.

What are the common drug interactions of Ipratropium Bromide and Pemetrexed Disodium, by gender? *:

female:

  1. Neck pain
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Death
  4. Procedural complication
  5. Abdominal pain upper
  6. Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
  7. Autoimmune pancreatitis (autoimmune pancreatitis (aip) is an increasingly recognized type of chronic pancreatitis)

male:

  1. Acute respiratory failure
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Dizziness
  4. Nausea (feeling of having an urge to vomit)
  5. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  6. Troponin i increased
  7. Vomiting
  8. Back pain
  9. Cardiac failure
  10. Cellulitis (infection under the skin)

What are the common drug interactions of Ipratropium Bromide and Pemetrexed Disodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Neck pain
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Dizziness
  5. Nausea (feeling of having an urge to vomit)
  6. Vomiting
  7. Abdominal pain upper
  8. Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
  9. Autoimmune pancreatitis (autoimmune pancreatitis (aip) is an increasingly recognized type of chronic pancreatitis)

60+:

  1. Acute respiratory failure
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Procedural complication
  4. Troponin i increased
  5. Back pain
  6. Cardiac failure
  7. Cellulitis (infection under the skin)
  8. Chest pain
  9. Lung disorder (lung disease)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 9 people, 60.00%
  2. Dyspnea (difficult or laboured breathing): 4 people, 26.67%
  3. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 20.00%
  4. Nausea (feeling of having an urge to vomit): 3 people, 20.00%
  5. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 20.00%
  6. Lung Neoplasm Malignant (cancer tumour of lung): 3 people, 20.00%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 20.00%
  8. Nausea And Vomiting: 3 people, 20.00%
  9. Pain: 3 people, 20.00%
  10. Sleep Disorder: 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and Pemetrexed disodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ipratropium bromide and Pemetrexed disodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pemetrexed disodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ipratropium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pemetrexed disodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and pemetrexed disodium (the active ingredients of Ipratropium bromide and Pemetrexed disodium, respectively), and Ipratropium bromide and Pemetrexed disodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: